Find an expert

Dr. Halley Ravuri completed his Bachelor of Veterinary Science degree from the Orissa University of Agriculture and Technology, and a Master in Pharmacology and Toxicology from the Birsa Agricultural University, India. He recently finished his PhD in Veterinary Science at UQ in 2022. Before his PhD, he worked as a Research Associate in various research organizations for four years in India. His primary research was focused on developing cancer models for glioma (brain cancer), breast cancer, and melanoma in laboratory rodents, and investigating the efficacy of nano-particulated anticancer compounds. He is very experienced in maintaining, experimenting on laboratory rodents and has hands-on experience in research methodologies including ELISA, PCR, western blot analysis, histopathology, and bioanalytical analysis using HPLC instrumentation

His doctoral research was focused on transdermal drug delivery of nonsteroidal anti-inflammatory drugs (NSAIDs) in veterinary species and evaluating the efficacy of novel transdermal formulations using mass spectrometry-based plasma proteomics and lipidomics. He has garnered tremendous interest and expertise in the use of advanced mass spectrometry instruments including LC-MS/MS, GC-MS, and LC-TOF-MS, for enabling both targeted and discovery analysis of proteins, drugs, and lipid metabolites in animal plasma/serum. He has also worked as a technical assistant at the Analytical Service Unit, School of Agriculture and Food Sciences, UQ, using mass spectrometry for the analysis of pesticides, and fatty acid composition in milk, soils, and food samples.

Dr. Halley Ravuri is working at The School of Biomedical Sciences, Faculty of Medicine, UQ – as a Postdoctoral Research Fellow, under the supervision of Prof. Mark Midwinter. His current research goals are to characterize endothelial glycocalyx metabolites in serum/plasma using advanced mass spectrometry techniques, and also explore the pathophysiology of trauma and hemorrhagic shock using a proteomics-based approach. He also has a keen interest in exploring alternative in-vitro techniques to investigate endothelial glycocalyx, and examining the role of exosomes in trauma/hemorrhagic shock in animals and humans. His long-term goal is to establish himself as a translational proteomics expert in the field of plasma biomarker discovery and establish novel mass spectrometry methods and data analysis pipelines to improve the application of mass spectrometry research in the veterinary and translation biomedical sciences. He is an advocate of the use of mass spectrometry-based proteomics to contribute to the field of “One Health”; using veterinary species as translational models for studying human diseases. His future research goals include exploring viral proteomics to investigate and understand the virulence of viruses, characterise viral antibodies using mass spectrometry and studying physiological responses in animals, humans, and model organisms.

I received my Bachelor's in Biology (2001) from Yarmouk University in Jordan, followed by postgraduate degrees from the University of Houston in Houston-Texas (2002-2007). My studies are integrative in nature, joining the best of both the Neuroscience world and Circadian Biology (the study of biological clocks). In the laboratory of Prof. Arnold Eskin, I investigated how processes as complex as learning and memory are modulated by biological clocks i.e. the circadian (about 24 hours) system, using Aplysia californica as the experimental model. After completing my Master's in Science in 2005, my research focused on the mechanism by which biological clocks modulate learning and memory. This work was performed in the laboratories of Prof. Gregg Cahill and Prof. Greg Roman, experts in chronobiology and behavioral neuroscience, respectively. Using Zebrafish as a model system, I investigated the role of melatonin, a night-time restricted hormonal signal, in modulating long-term memory consolidation. My findings, published in Science in 2007, shows that the circadian system via the cyclic night-time confined synthesis/release of melatonin “the hormone of darkness” functions as a modulator, shaping daily variations in the efficiency by which memories are processed. After receiving my Ph.D. in 2007, I joined as a postdoctoral fellow the laboratory of the pharmacologist and melatonin researcher Prof. Margarita Dubocovich. My postdoctoral work engaged in elucidating the role of melatonin in circadian physiology and pharmacology during development and ageing in rodents (Mus musculus) and non-human primates (Macaca mulatta) at the Feinberg School of Medicine (Northwestern University-Chicago) and the State University of New York (SUNY). From 2010-2015, I held a teaching/research position in the Dr. Senckenbergische Anatomy and the Dept. of Neurology at the Goethe University in Frankfurt-Germany. During this time, I was involved in teaching gross human anatomy while continuing my endeavor in understanding the mechanistics involved in shaping memory processes (acquisition, consolidation and retrieval) by the circadian system.

Gillian Ray-Barruel, RN PhD, is a Senior Research Fellow with UQ School of Nursing, Midwifery and Social Work and the Herston Infectious Diseases Institute (HeIDI), and she is Director of Education with the Alliance for Vascular Access Teaching and Research (AVATAR) and Associate Editor for the journal Infection, Disease & Health.

Formerly a critical care nurse and research coordinator, Gillian has 15 years of vascular access research experience, with an emphasis on device assessment and clinical decision making to improve patient outcomes. After identifying a gap between evidence-based guidelines and clinical practice, she created the I-DECIDED® device assessment and decision tool, which has been included in several textbooks and disseminated in multiple languages and is in use in many hospitals worldwide.

Professor Reade is Director of the Greater Brisbane Clinical School and Professor of Military Medicine and Surgery at UQ. The Greater Brisbane Clinical School comprises all the Brisbane teaching hospitals of the University of Queensland along with the preclinical teaching resources of the St Lucia campus and the General Practice Clinical Unit. A specialist intensive care physician, anaesthetist and clinician-researcher, he also leads a program of research relevant to military trauma medicine and surgery that holds equal promise for severely injured civilian trauma patients.

After clinical training in anaesthetics and intensive care medicine in Sydney, Melbourne, Oxford and Pittsburgh, a doctorate in the molecular pathogenesis of nitric oxide production in human septic shock from the University of Oxford and a postdoctoral research fellowship in clinical trials and epidemiology from the University of Pittsburgh, Michael returned to Australia as Associate Professor of Intensive Care Medicine at the Austin Hospital & the University of Melbourne in 2007. Michael held faculty appointments at the University of Oxford (where he taught physiology), the University of Pittsburgh (where he was an Instructor in critical care), and currently holds adjunct or honorary appointments at the University of London, the US Uniformed Services University of the Health Sciences, the University of Melbourne and Monash University. He has supervised postgraduate students in basic, applied and clinical research, and is a Fellow of the Higher Education Academy of the United Kingdom.

In parallel with his academic and clinical work, Michael served in the Australian Army Reserve until his appointment to the full-time ADF Chair in 2011. He was commissioned as a General Service Officer in the Australian Army in 1990, and prior to his appointment to UQ had deployed to Bosnia and Kosovo (on attachment to the British Airborne Brigade), Timor, the Solomon Islands and Afghanistan. In 2013 he commanded the Australian Specialist Health Group at the NATO ISAF Role 3 Hospital in Kandahar, Afghanistan, and in 2015 in Iraq he was the first Director of Clinical Services of the ADF hospital deployed in support of Operation Inherent Resolve. He deployed again to Iraq in 2016 and 2017. From 2015-2018 he was the Director of Clinical Services of the Australian Regular Army's only field hospital. In 2017 he led this unit to become the first ever ADF hospital accredited by the Royal Australasian College of Surgeons Trauma Verification Program. He was recognised for this service by appointment as a Member in the Military Division of the Order of Australia in the 2019 Queen's Birthday Honours List. From 2019-2022 on promotion to Brigadier he was appointed Director General Health Reserve - Army, responsible for technical regulation of specialist medical, nursing and allied health support. He remains a senior clinical advisor to Joint Health Command of the Australian Defence Force.

Professor Reade's clinical research focusses on treatments for exsanguinating haemorrhage, improving trauma systems, and preventing and treating acute cognitive impairment (such as that which results from traumatic brain injury). He is the Chief Investigator in an NHMRC-funded clinical trial of cyropreserved (frozen) platelets, a technology which holds equal promise to military and civilian trauma patients, particularly those in smaller hospitals. He is also a Chief Investigator in NHMRC-funded multicentre clinical trials of tranexamic acid and fibrinogen concentrate (drugs thought to reduce mortality from traumatic bleeding), the effect of erythropoietin on inflammation and mortality after severe trauma, a novel anti-delirium strategy for use in critically ill patients, and an advanced MRI/biomarker study in traumatic brain injury. He has active research collaborations with Australian Red Cross Lifeblood, the National Trauma Research Institute, the Australian and New Zealand Intensive Care Research Centre at Monash University, the ANZICS Clinical Trials Group and the ANZCA Clinical Trials Network.

Professor Reade is also developing a research programme focussed on trauma systems design, in collaboration with colleagues at the Jamieson Trauma Institute on the Royal Brisbane and Women's Hospital campus, Australian state ambulance services and the US and UK armed forces, aiming (for example) to optimise the allocation of prehospital and hospital resources in the management of life-threatening trauma.

Professor Reade currently supervises 10 postgraduate students (including 4 PhD students) and one postdoctoral research fellow, most of whom are Defence Force officers. He holds or has held research grants totalling >A$51M, has published >230 peer-reviewed papers and delivered >440 lectures at national and international conferences. From 2019-2021, Professor Reade was President of the Australasian Trauma Society.

Mario Jr Rebosura received his Bachelor of Science in Chemical Engineering (2009) from the University of the Philippines Los Banos and his Masters of Engineering in Environmental Engineering (2012) from the Catholic University of Korea. After his Masters he has worked in the process automation, process engineering, and project management for several years. He received his PhD in Chemical Engineering (2020) from the University of Queensland under the Australian Centre for Water and Environmental Biotechnology (formerly AWMC) and is currently a postdoctoral research fellow in the same centre.

Mario’s expertise involves the areas of integrated urban water management, anaerobic technologies, and resource recovery. His goal is to produce high impact research that combines fundamental and engineering knowledge to produce scientific discoveries that can translate to real life applications. He has published several top-tiered peer-reviewed international journal papers. He also serves as an Editor for International Research Journal on Innovations in Engineering, Science and Technology published by the Batangas State University Philippines and a reviewer for several international journals. His research was also presented in many international conferences that lead to speaking invitation and organising workshops.

Overview

Professor Tim Reddel is leading the Social Solutions Group at the Institute for Social Science Research, University of Queensland. The Group aims to create greater public policy impact for social science knowledge and research through more collaborative, evidenced based, and mutually beneficial partnerships between researchers, end users and citizens.

Prior to his appointment to the Institute in August 2019, Professor Reddel worked in a range of senior executive roles in the Australian and Queensland public service, the community services sector and academia. He has previously led the Australian Government’s Department of Social Services’ Policy Office which was responsible for evidence, data analysis, research and evaluation strategies to support and enable quality strategic social policy. Professor Reddel joined the Australian Public Service in 2010 as Deputy Coordinator General for Remote Indigenous Services and has longstanding interest and experience in Indigenous policy and practice. Professor Reddel is also an Adjunct Professor with the Cities Research Institute at Griffith University and was appointed to the Australian Research Council’s Engagement and Impact Assessment Panel for Social Sciences in 2018 to examine how well universities were engaging with research end-users and delivering policy impact.

He has written numerous research articles, papers and reports on social policy governance, locational disadvantage, place based interventions and participatory policy approaches including in the Australian Journal of Public Administration, the Australian Journal of Social Issues and the International Journal of Urban and Regional Research. He also co-edited a book, Community and Local Governance in Australia published by UNSW Press in 2005.

Research interests

Place based policy interventions

Networks and participatory governance

Locational disadvantage

Implementation science, policy impact and research translation

Integrating policy co-design, co-production and data analysis

Dr Andrew Redmond is a specialist physician in infectious diseases medicine with clinical interests in general infectious diseases medicine, immunization, antibiotic allergy, HIV and sexual health. He has research interests in malaria, HIV and sexual health, and health issues in Aboriginal and Torres Strait Islanders, especially in remote settings. He has extensive experience teaching medical students, doctors and other health care workers on clinical reasoning, infectious diseases, and HIV.

He holds adjunct appointments in the School of Medicine at the University of Queensland and the Griffith Institute of Drug Discovery at Griffith University. He is the Clinical Director of the Infectious Diseases Unit at the Royal Brisbane and Women's Hospital and Clinical Supervisor for the RAPID HIV/STI Testing Program of QPP.

Associate Prof Amy McCart Reed holds a PhD in molecular biology from The University of Queensland. She is a Fellow of the Faculty of Science of the Royal College of Pathologists Australasia. Her early postdoctoral work focused on understanding the genetic basis of colorectal cancer using experimental disease models, as part of a Cancer Research UK-funded colorectal cancer program led by Professors Ian Tomlinson and Andrew Silver. After returning to Australia, she was recruited to the Molecular Breast Pathology group at UQ’s Centre for Clinical Research and has undertaken a series of studies investigating the genomic landscape of breast cancer special types. Amy's research program includes studies on Metaplastic breast cancer and Invasive Lobular Carcinoma, two breast cancer special types in need of targetted therapy options. A/Prof McCart Reed is the scientific lead on an MRFF-funded genomics program investigating the potential for the application of Whole Genome Sequencing in the breast cancer care pathway in Australia, 'Q-IMPROvE'. She applies genomics and spatial transcriptomics methodologies to archival clinical samples to understand the differences between tumour types and their potential for treatment. Amy is passionate about clinical research, biobanking and precision oncology. In addition to her breast cancer research portfolio, she is on the steering committee for the Brisbane Breast Bank and the Scientific Advisory Board for Breast Cancer Trials.

Dr Sarah Reedman is a Postdoctoral Research Fellow at the Queensland Cerebral Palsy and Rehabilitation Research Centre group within the UQ Child Health Research Centre. Sarah is passionate about enabling participation of young people with disabilities in sports and active recreation. She is interested demonstrating how paediatric physiotherapists, occupational therapists and exercise physiologists are well-placed to deliver effective physical activity promotion interventions in young people with disabilites. Sarah is also involved in the conduct of a large, multi-site randomized controlled trial of an intensive functional goal-directed motor training intervention in children with bilateral cerebral palsy (Hand Arm Bimanual Intensive Training Including Lower Extremity [HABIT-ILE]).

Sarah is experienced in the following research methods:

• Design, conduct and administration of randomized controlled trials (including multi-site trials)
• Cross-sectional and cohort studies
• Validation of rehabilitation outcome measures
• Objective measurement of physical activity behaviours, tri-axial accelerometry

Sarah is available as an associate supervisor for HDR students.

Dr. Matt Reeves completed his PhD degree in theoretical physics from the University of Otago (New Zealand) in 2016. During his PhD, he worked in the field of vortex dynamics and turbulence in quantum fluids, under the supervision of Dr. Ashton Bradley.

In 2017, he joined the group of Prof. Matthew Davis at the University of Queensland as a Postdoctoral Research Fellow, studying far-from-equilibrium physics in exciton-polariton and atomic Bose-Einstein condensates.

Navin Sam Regi (Sam), is an award-winning documentary producer and digital storytelling expert with a decade of experience in creating socially impactful narratives. His work, rooted in capturing untold stories and amplifying marginalised voices, spans across community-focused journalism, healthcare documentation, and innovative oral history projects.

His storytelling expertise extends to projects like My Little Sunshine, documenting grief in partnership with Queensland's only children’s hospice, and the groundbreaking First 100 Days of Voluntary Assisted Dying project with Metro North and QUT. Sam is also the founder of Talking Stories, specialising in personalised storytelling, with high-profile collaborations such as the Indian Diaspora Oral History Project with the National Library of Australia.

As a Teaching Associate at the University of Queensland, Sam also brings his industry experience to academia, where he coordinates courses in social justice storytelling and media strategies. His MPhil research explored process journalism in aged care, a topic on which he has published.

Prof Peter Reher is a German and Australian citizen, living in Australia since 2009. He is a registered dentist and a specialist in Oral Surgery with AHPRA.

Peter lived in Brazil for many years and graduated in Dentistry at PUC-Minas Faculty of Dentistry in 1987. He subsequently completed his residency and Master’s in Oral & Maxillofacial Surgery in 1992. He worked in Brazil as an OMF Surgeon for 20 years, both in private practice and hospitals, in oral surgery, implantology, trauma and orthognathic surgery. Between 1995 and 1999, Peter obtained his PhD at the Eastman Dental Institute in London, funded by a grant from the Brazilian Research Council (CNPq).

Prof Reher worked as a senior lecturer and associate professor in Anatomy at the Federal University of Minas Gerais (Brazil) between 1989 and 2009. In 2004 Peter joined the PUC-Minas University as an associated professor, where he was involved in training specialists in Oral & Maxillofacial Surgery and Implantology. Peter was one of the coordinators of the Brazilian College of Oral & Maxillofacial Surgeons (affiliated with the IAOMS).

Prof Reher moved to Australia in 2009 as the Professor of Oral & Maxillofacial Surgery at the Griffith University School of Dentistry and Oral Health, where he was the discipline lead in the area for 14 years. He taught regularly in UG and PG programs and was the Program Director of the Master of Clinical Dentistry (Oral Surgery). He was the Deputy Head of School for five years and the Clinical Director of the Griffith Dental Clinic for another five years. Peter has chaired several committees and implemented the first clinic accreditation towards the Australian National Safety and Quality Health Service Standards.

Peter has published several articles and textbooks throughout his career, having presented his work at many international conferences. He has supervised several research projects, including PhD’s, Master’s, Honours, and Specialist’s thesis. Peter also received awards from the Royal Society of Medicine, University College London Medical School and the International Journal of Oral & Maxillofacial Surgery.

Peter is the Director of the Oral Health Alliance, a partnership between Metro North Health and UQ’s School of Dentistry. He is also a Professor of Oral Surgery at the School of Dentistry, University of Queensland. Peter is married, has two children, and enjoys cooking, sailing, and spending time with his family.

Dr Reichelt is a tenured teaching and research academic in The University of Queensland’s School of Biomedical Sciences. She completed her PhD in cardiovascular Physiology at Griffith University, and held postdoctoral positions at The Victor Chang Cardiac Research Institute (VCCRI) in Sydney, the University of California, San Diego (USA) and was a NHMRC Peter Doherty Postdoctoral Fellow at the University of Melbourne. Dr Reichelt is currently funded by two Australian Research Council Discovery Project Grants and lead a 2019 Major Equipment Infrastructure Grant for a preclinical ultrasound machine (Vevo 3100) which measures cardiac function in animals as small as embryos in utero.

Dr Reichelt investigated the most important receptors governing cardiac function (adenosinergic, adrenergic, angiotensin, growth factor, mineralocorticoid, SGLT2), and the influence of ageing, diabetes, hypertension, exercise, influenza and sepsis on cardiovascular physiology. This work has been published in leading cardiovascular journals including Circulation Research, Basic Research in Cardiology, Cardiovascular Research, Hypertension and broader or other specialist journals such as Autophagy, Antioxidant and Redox Signalling, Journal of Infectious Disease and Scientific Reports. Dr Reichelt’s research has most recently been augmented by in-house design and production of viruses that control the expression of receptors and their ligands. She remains fascinated by what the heart can accomplish; filling with and ejecting blood every second (or so) of every day and night, year after year, while retaining the capacity to more than treble cardiac output during exercise. It’s an incredible feat of engineering and only gets more and more interesting the more I learn about it.